This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen.
Prostate. 2009 Feb 1;69(2):159-67. doi: 10.1002/pros.20860.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Characterization of PKD protein-positive exosome-like vesicles.
J Am Soc Nephrol. 2009 Feb;20(2):278-88. doi: 10.1681/ASN.2008060564. Epub 2009 Jan 21.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)Q64105Characterization of vesicles secreted from insulinoma NIT-1 cells.
J Proteome Res. 2009 Jun;8(6):2851-62. doi: 10.1021/pr900009y.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.
Mol Cell Proteomics. 2009 Oct;8(10):2201-11. doi: 10.1074/mcp.M900203-MCP200. Epub 2009 Jun 29.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P18297Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.
Proteomics Clin Appl. 2010 Apr;4(4):416-25. doi: 10.1002/prca.200900103.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P18297Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P18297Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P18297Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)Q17QK8Bovine milk exosome proteome.
J Proteomics. 2012 Feb 16;75(5):1486-92. doi: 10.1016/j.jprot.2011.11.017. Epub 2011 Nov 23.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Fragment)Q93041Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Fragment)Q93041Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Fragment)Q93041Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270LRRK2 secretion in exosomes is regulated by 14-3-3.
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Fragment)Q93041Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Fragment)Q93041Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductaseG3UXX3Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Sepiapterin reductase, isoform CRA_b)Q91XH5Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)Q64105Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Methods. 2015 Apr 16. pii: S1046-2023(15)00154-1. doi: 10.1016/j.ymeth.2015.04.008.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Methods. 2015 Apr 16. pii: S1046-2023(15)00154-1. doi: 10.1016/j.ymeth.2015.04.008.
ENOG4111PZG146 / 0 / 146
Deleted.F6SZQ1Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)Q64105A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)Q64105A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel biomarker for early breast cancer detection.
Clin Cancer Res. 2015 Nov 24. pii: clincanres.0654.2015.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
ENOG4111PZG146 / 0 / 146
Uncharacterized proteinF1PTP2Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells.
Oncotarget. 2016 Feb 22. doi: 10.18632/oncotarget.7573.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductaseG3UXX3Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductaseG3UXX3Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR.
Mol Neurodegener. 2016 May 23;11(1):41. doi: 10.1186/s13024-016-0108-1.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Sepiapterin reductase, isoform CRA_b)Q91XH5Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Sepiapterin reductase, isoform CRA_b)Q91XH5Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (Sepiapterin reductase, isoform CRA_b)Q91XH5Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
Sepiapterin reductase (SPR) (EC 1.1.1.153)P35270Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111PZG146 / 0 / 146
[1] [2]